UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054244
Receipt number R000061943
Scientific Title Preimplantaion testing for monogenic disease(congenital myopathy)
Date of disclosure of the study information 2024/07/01
Last modified on 2024/04/24 11:26:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preimplantion testing for monogenic disease(congenital myopathy)

Acronym

Preimplantaion testing for monogenic disease(congenital myopathy)

Scientific Title

Preimplantaion testing for monogenic disease(congenital myopathy)

Scientific Title:Acronym

Preimplantation testing for monogenic disease(congenital myopathy)

Region

Japan


Condition

Condition

congenital myopathy

Classification by specialty

Neurology Obstetrics and Gynecology Pediatrics

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Not to deliver affected fetus

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

delivery to a baby without congenital myopathy

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

trophectderm biopsy, DNA extraction, whole genome, genetic testing for SCN4A

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

compound heterozygous of SCN4A

Key exclusion criteria

none

Target sample size

1


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Iwasa

Organization

Tokushima University Hospital

Division name

Obstetrics and Gynecology

Zip code

770-8503

Address

3-18-15 Kuramoto-cho, Tokushima

TEL

0886337177

Email

yamamoto.yuri@tokushima-u.ac.jp


Public contact

Name of contact person

1st name Yuri
Middle name
Last name Yamamoto

Organization

Tokushima University Hospital

Division name

Obstetrics and Gynecology

Zip code

770-8503

Address

3-18-15 Kuramoto-cho, Tokushima

TEL

0886337177

Homepage URL


Email

yamamoto.yuri@tokushima-u.ac.jp


Sponsor or person

Institute

Tokushima University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

tokushima university hospital

Address

3-18-15 Kuramoto-cho, Tokushima

Tel

0886337177

Email

yamamoto.yuri@tokushima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

1

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 04 Month 01 Day

Date of IRB

2024 Year 04 Month 19 Day

Anticipated trial start date

2024 Year 06 Month 01 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 04 Month 24 Day

Last modified on

2024 Year 04 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061943